New drugs, procedures, and devices for hypertension
Successful treatment of hypertension is difficult despite the availability of several classes of
antihypertensive drug, and the value of strategies to combat the effect of adverse lifestyle …
antihypertensive drug, and the value of strategies to combat the effect of adverse lifestyle …
Novel therapeutic targets for the treatment of heart failure
J Tamargo, J Lopez-Sendon - Nature reviews Drug discovery, 2011 - nature.com
Despite considerable therapeutic advances, heart failure remains a medical and
socioeconomic problem. Thus, there is a compelling need for new drugs that could improve …
socioeconomic problem. Thus, there is a compelling need for new drugs that could improve …
Novel therapeutic targets for hypertension
Despite the existence of established, effective therapies for hypertension, new methods of
blood pressure and cardiovascular risk reduction are still needed. Novel approaches are …
blood pressure and cardiovascular risk reduction are still needed. Novel approaches are …
Therapeutic perspectives in hypertension: novel means for renin–angiotensin–aldosterone system modulation and emerging device-based approaches
The conventional antihypertensive therapies including renin–angiotensin–aldosterone
system antagonists (converting enzyme inhibitors, receptor blockers, renin inhibitors, and …
system antagonists (converting enzyme inhibitors, receptor blockers, renin inhibitors, and …
The (pro) renin receptor and its interaction partners
J Peters - Pflügers Archiv-European Journal of Physiology, 2017 - Springer
The prorenin receptor was originally discovered as a receptor that binds renin and prorenin,
thereby inducing pro-fibrotic intracellular signal cascades. These effects are partially …
thereby inducing pro-fibrotic intracellular signal cascades. These effects are partially …
The (pro) renin receptor as a pharmacological target in cardiorenal diseases
H Funke-Kaiser, T Unger - Hypertension Research, 2023 - nature.com
Abstract The (pro) renin receptor ((P) RR) is not only a member of the renin-angiotensin
system (RAS) but also exerts several RAS-independent functions due to its multiple signal …
system (RAS) but also exerts several RAS-independent functions due to its multiple signal …
(Pro) renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis
T Peltonen, J Näpänkangas, P Ohtonen, J Aro… - Atherosclerosis, 2011 - Elsevier
BACKGROUND: There is increasing evidence that renin–angiotensin system (RAS) may
play a major role in the actively regulated fibrocalcific process in aortic valve stenosis (AS) …
play a major role in the actively regulated fibrocalcific process in aortic valve stenosis (AS) …
Cardiovascular and renal pathologic implications of prorenin, renin, and the (pro) renin receptor: promising young players from the old renin-angiotensin-aldosterone …
P Balakumar, G Jagadeesh - Journal of cardiovascular …, 2010 - journals.lww.com
The overactivation of the renin-angiotensin-aldosterone system accounts for many
cardiovascular and renal abnormalities. At several levels of its cascade, the renin …
cardiovascular and renal abnormalities. At several levels of its cascade, the renin …
New antihypertensive drugs under development
Hypertension is the most common cardiovascular disease and remains the most prevalent
risk factor for cardiovascular diseases and a major cause of death worldwide. Despite the …
risk factor for cardiovascular diseases and a major cause of death worldwide. Despite the …
Novel regulators and drug targets of cardiac hypertrophy
P Finckenberg, E Mervaala - Journal of hypertension, 2010 - journals.lww.com
Cardiac hypertrophy is classically considered as an adaptive and compensatory response
enabling cardiomyocytes to increase their work output and thus cardiac function …
enabling cardiomyocytes to increase their work output and thus cardiac function …